Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: March 13, 2024
Abstract
Tissue-resident
macrophages
play
an
important
role
in
the
local
maintenance
of
homeostasis
and
immune
surveillance.
In
central
nervous
system
(CNS),
brain
are
anatomically
divided
into
parenchymal
microglia
non-parenchymal
border-associated
(BAMs).
Among
these
cell
populations,
have
been
well-studied
for
their
roles
during
development
as
well
health
disease.
BAMs,
mostly
located
choroid
plexus,
meningeal
perivascular
spaces,
now
gaining
increased
attention
due
to
advancements
multi-omics
technologies
genetic
methodologies.
Research
on
BAMs
over
past
decade
has
focused
ontogeny,
immunophenotypes,
involvement
various
CNS
diseases,
potential
therapeutic
targets.
Unlike
microglia,
display
mixed
origins
distinct
self-renewal
capacity.
believed
regulate
neuroimmune
responses
associated
with
barriers
contribute
immune-mediated
neuropathology.
Notably,
observed
function
diverse
cerebral
pathologies,
including
Alzheimer’s
disease,
Parkinson’s
multiple
sclerosis,
ischemic
stroke,
gliomas.
The
elucidation
heterogeneity
functions
neuroinflammation
is
mesmerizing,
since
it
may
shed
light
precision
medicine
that
emphasizes
deep
insights
programming
cues
unique
microenvironment.
this
review,
we
delve
latest
findings
covering
aspects
like
origins,
capacity,
adaptability,
implications
different
disorders.
Cell Communication and Signaling,
Journal Year:
2020,
Volume and Issue:
18(1)
Published: April 15, 2020
Abstract
Traumatic
brain
injury
(TBI)
is
one
of
the
leading
causes
fatality
and
disability
worldwide.
Despite
its
high
prevalence,
effective
treatment
strategies
for
TBI
are
limited.
induces
structural
functional
alterations
astrocytes,
most
abundant
cell
type
in
brain.
As
a
way
coping
with
trauma,
astrocytes
respond
diverse
mechanisms
that
result
reactive
astrogliosis.
Astrocytes
involved
physiopathologic
an
extensive
sophisticated
manner.
Notably,
have
dual
roles
TBI,
some
astrocyte-derived
factors
double
opposite
properties.
Thus,
suppression
or
promotion
astrogliosis
does
not
substantial
curative
effect.
In
contrast,
selective
stimulation
beneficial
molecules
simultaneous
attenuation
deleterious
based
on
spatiotemporal-environment
can
provide
promising
astrocyte-targeting
therapeutic
strategy.
current
review,
we
describe
first
time
specific
neuronal
plasticity
reconstruction,
including
neurogenesis,
synaptogenesis,
angiogenesis,
repair
blood-brain
barrier,
glial
scar
formation
after
TBI.
We
also
classified
depending
their
neuroprotective
neurotoxic
to
design
more
appropriate
targeted
therapies.
Biomedicines,
Journal Year:
2020,
Volume and Issue:
8(10), P. 389 - 389
Published: Sept. 29, 2020
Studying
the
complex
molecular
mechanisms
involved
in
traumatic
brain
injury
(TBI)
is
crucial
for
developing
new
therapies
TBI.
Current
treatments
TBI
are
primarily
focused
on
patient
stabilization
and
symptom
mitigation.
However,
field
lacks
defined
to
prevent
cell
death,
oxidative
stress,
inflammatory
cascades
which
lead
chronic
pathology.
Little
can
be
done
treat
mechanical
damage
that
occurs
during
primary
insult
of
a
TBI;
however,
secondary
mechanisms,
such
as
inflammation,
blood-brain
barrier
(BBB)
breakdown,
edema
formation,
excitotoxicity,
targeted
by
therapeutic
interventions.
Elucidating
many
underlying
studying
targets
neuroprotective
agents
critical
treatments.
Therefore,
we
present
review
events
following
from
inflammation
programmed
death
discuss
current
research
latest
strategies
help
understand
TBI-mediated
injury.
Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: June 15, 2020
Abstract
Background
Aucubin
(Au),
an
iridoid
glycoside
from
natural
plants,
has
antioxidative
and
anti-inflammatory
bioactivities;
however,
its
effects
on
a
traumatic
brain
injury
(TBI)
model
remain
unknown.
We
explored
the
potential
role
of
Au
in
H
2
O
-induced
oxidant
damage
primary
cortical
neurons
weight-drop
induced-TBI
mouse
model.
Methods
In
vitro
experiments,
various
concentrations
(50
μg/ml,
100
or
200
μg/ml)
were
added
culture
medium
at
0
h
6
after
stimulated
by
(100
μM).
After
exposed
for
12
h,
collected
western
blot
(WB),
immunofluorescence,
M29,79-dichlorodihydrofluorescein
diacetate
(DCFH-DA)
staining.
vivo
(20
mg/kg
40
mg/kg)
was
administrated
intraperitoneally
30
min,
24
48
modeling.
Brain
water
content,
neurological
deficits,
cognitive
functions
measured
specific
time,
respectively.
Cortical
tissue
around
focal
trauma
WB,
TdT-mediated
dUTP
Nick-End
Labeling
(TUNEL)
staining,
Nissl
quantitative
real
time
polymerase
chain
reaction
(q-PCR),
immunofluorescence/immunohistochemistry,
enzyme
linked
immunosorbent
assay
(ELISA)
72
TBI.
RNA
interference
experiments
performed
to
determine
nuclear
factor
erythroid-2
related
(Nrf2)
TBI
mice
with
(40
treatment.
Mice
intracerebroventricularly
lentivirus
before
establishment.
The
cortex
obtained
used
WB
q-PCR.
Results
enhanced
translocation
Nrf2
into
nucleus,
activated
antioxidant
enzymes,
suppressed
excessive
generation
reactive
oxygen
species
(ROS),
reduced
cell
apoptosis
both
experiments.
TBI,
markedly
attenuated
edema,
histological
damages,
improved
deficits.
significantly
high
mobility
group
box
1
(HMGB1)-mediated
aseptic
inflammation.
knockdown
blunted
neuroprotective
Au.
Conclusions
Taken
together,
our
data
suggest
that
provides
effect
inhibiting
oxidative
stress
inflammatory
responses;
mechanisms
involve
triggering
Nrf2-induced
system.
Frontiers in Aging Neuroscience,
Journal Year:
2022,
Volume and Issue:
14
Published: March 25, 2022
Traumatic
brain
injury
(TBI)
is
one
of
the
most
common
diseases
in
central
nervous
system
(CNS)
with
high
mortality
and
morbidity.
Patients
TBI
usually
suffer
many
sequelae
life
time
post
injury,
including
neurodegenerative
disorders
such
as
Alzheimer’s
disease
(AD)
Parkinson’s
(PD).
However,
pathological
mechanisms
connecting
these
two
processes
have
not
yet
been
fully
elucidated.
It
important
to
further
investigate
pathophysiological
underlying
TBI-induced
neurodegeneration,
which
will
promote
development
precise
treatment
target
for
notorious
consequences
after
TBI.
A
growing
body
evidence
shows
that
neuroinflammation
a
pivotal
process
chronic
neurodegeneration
following
Microglia,
immune
cells
CNS,
play
crucial
roles
other
CNS
diseases.
Of
interest,
microglial
activation
functional
alteration
has
proposed
key
mediators
evolution
pathology
Here,
we
review
updated
studies
involving
phenotypical
alterations
microglia
survey
molecules
regulating
activities
responses
pathology,
explore
their
potential
implications
injury.
The
work
give
us
comprehensive
understanding
driving
TBI-related
offer
novel
ideas
developing
corresponding
prevention
strategies
this
disease.
Frontiers in Physiology,
Journal Year:
2021,
Volume and Issue:
12
Published: Oct. 22, 2021
Traumatic
brain
injury
(TBI)
is
a
heterogeneous
disorder
that
involves
damage
due
to
external
forces.
TBI
the
main
factor
of
death
and
morbidity
in
young
males
with
high
incidence
worldwide.
causes
central
nervous
system
(CNS)
under
variety
mechanisms,
including
synaptic
dysfunction,
protein
aggregation,
mitochondrial
oxidative
stress,
neuroinflammation.
Glial
cells
comprise
most
CNS,
which
are
mediators
brain’s
response
TBI.
In
CNS
present
astrocytes,
microglia,
oligodendrocytes,
polydendrocytes
(NG2
cells).
Astrocytes
play
critical
roles
ion
water
homeostasis,
energy
metabolism,
blood-brain
barrier,
immune
response.
TBI,
astrocytes
change
their
morphology
expression.
Microglia
primary
phagocytic
activity.
After
microglia
also
release
both
pro
anti-inflammatory
mediators.
Oligodendrocytes
myelin
producers
promoting
axonal
support.
oligodendrocyte
apoptosis,
demyelination,
transport
disruption.
There
various
interactions
between
these
glial
neurons
contribute
pathophysiology
this
review,
we
summarize
several
hallmarks
relevant
for
understanding
neuronal
conditions.
JAMA Network Open,
Journal Year:
2022,
Volume and Issue:
5(4), P. e229478 - e229478
Published: April 28, 2022
Increased
risk
of
neurological
and
psychiatric
conditions
after
traumatic
brain
injury
(TBI)
is
well-defined.
However,
cardiovascular
endocrine
comorbidity
TBI
in
individuals
without
these
comorbidities
associations
with
post-TBI
mortality
have
received
little
attention.To
assess
the
incidence
cardiovascular,
endocrine,
neurological,
patients
mild
(mTBI)
or
moderate
to
severe
(msTBI)
analyze
between
mortality.This
prospective
longitudinal
cohort
study
used
hospital-based
patient
registry
data
from
a
tertiary
academic
medical
center
select
any
prior
clinical
who
experienced
2000
2015.
Using
same
registry,
head
injuries,
unexposed
group,
target
were
selected
age-,
sex-,
race-frequency-matched
subgroups.
Patients
followed-up
for
up
10
years.
Data
analyzed
2021.Mild
trauma.Cardiovascular,
neurologic,
defined
based
on
International
Classification
Diseases,
Ninth
Revision
(ICD-9)
Statistical
Diseases
Related
Health
Problems,
Tenth
(ICD-10).
Associations
comorbidities,
as
well
mortality,
analyzed.A
total
4351
mTBI
(median
[IQR]
age,
45
[29-57]
years),
msTBI
47
[30-58]
46
years)
included
analyses.
In
each
45%
participants
women.
significantly
associated
higher
risks
disorders
compared
individuals.
particular,
hypertension
was
increased
both
(HR,
2.5;
95%
CI,
2.1-2.9)
2.4;
2.0-2.9)
groups.
Diabetes
1.9;
1.4-2.7)
1.4-2.6)
groups,
ischemic
stroke
transient
attack
also
2.2;
1.4-3.3)
3.6;
2.4-5.3)
All
subgroups
emerged
within
median
(IQR)
3.49
(1.76-5.96)
years
injury.
Risks
aged
18
40
age-matched
individuals:
5.9;
3.9-9.1)
3.9;
2.5-6.1)
while
hyperlipidemia
2.3;
1.5-3.4)
diabetes
4.6;
2.1-9.9)
group.
Individuals
msTBI,
patients,
had
(432
deaths
[9.9%]
vs
250
[5.7%];
P
<
.001);
postinjury
1.3;
1.1-1.7),
coronary
artery
disease
1.6-3.0),
adrenal
insufficiency
6.2;
2.8-13.0)
mortality.These
findings
suggest
that
severity
chronic
baseline
diagnoses.
Medical
observed
relatively
young
TBI.
Comorbidities
occurring
mortality.
These
need
targeted
screening
program
multisystem
diseases
TBI,
particularly
cardiometabolic
diseases.
Inflammopharmacology,
Journal Year:
2022,
Volume and Issue:
30(4), P. 1153 - 1166
Published: July 8, 2022
Abstract
Traumatic
brain
injury
(TBI)
is
an
important
global
health
concern
that
represents
a
leading
cause
of
death
and
disability.
It
occurs
due
to
direct
impact
or
hit
on
the
head
caused
by
factors
such
as
motor
vehicles,
crushes,
assaults.
During
past
decade,
abundance
new
evidence
highlighted
importance
inflammation
in
secondary
damage
response
contributes
neurodegenerative
neurological
deficits
after
TBI.
results
disruption
blood–brain
barrier
(BBB)
initiates
release
macrophages,
neutrophils,
lymphocytes
at
site.
A
growing
number
researchers
have
discovered
various
signalling
pathways
associated
with
initiation
progression
inflammation.
Targeting
different
(NF-κB,
JAK/STAT,
MAPKs,
PI3K/Akt/mTOR,
GSK-3,
Nrf2,
RhoGTPase,
TGF-β1,
NLRP3)
helps
development
novel
anti-inflammatory
drugs
management
Several
synthetic
herbal
both
neuroprotective
potential
showed
effective
results.
This
review
summarizes
pathways,
pathologies,
inflammatory
mediators,
pharmacological
potential,
current
status,
challenges
drugs.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(3), P. 1220 - 1246
Published: Jan. 1, 2022
Background:
Obesity
is
becoming
a
global
epidemic
and
reversing
the
pathological
processes
underlying
obesity
metabolic
co-morbidities
challenging.Obesity
induced
chronic
inflammation
including
brain
hallmark
of
via
gut-brain
axis.The
objective
this
study
was
to
develop
garlic
exosome-like
nanoparticles
(GaELNs)
that
inhibit
systemic
as
well
inflammatory
activity
reverse
HFD
in
mice.Methods:
GELNs
were
isolated
administrated
orally
into
fed
mice.GaELNs
fluorescent
labeled
for
monitoring
their
vivo
trafficking
route
after
oral
administration
quantified
number
particles
several
tissues.The
determined
by
measuring
cytokines
ELISA
real-time
PCR.Mitochondrial
membrane
permeability
microglial
cells
using
JC-10
fluorescence
dye.The
apoptotic
cell
death
TUNEL
assay.The
metabolites
identified
LC-MS
analysis.Memory
function
mice
memory
functional
analysis.The
effect
GaELNs
on
glucose
insulin
response
tolerance
tests.c-Myc
localization
interaction
with
BASP1
calmodulin
confocal
microscopy.Results:
Our
results
show
preferentially
taken
up
inhibits
mice.GaELN
phosphatidic
acid
(PA)
(36:4)
required
uptake
BASP1.Formation
GaELNs/BASP1
complex
inhibition
c-Myc
mediated
expression
STING.GaELN
PA
binds
BASP1,
leading
through
competitively
binding
CaM
transcription
factor.Inhibition
STING
leads
reducing
an
array
IFN-γ
TNF-α.IFN-γ
induces
IDO1,
which
turn
generated
IDO1
dependent
manner
activate
AHR
pathway
contributes
developing
obesity.The
derived
from
treated
promote
neuronal
differentiation
mitochondrial
death.GaELNs
showed
improved
increased
sensitivity
these
mice.Conclusion:
Collectively,
demonstrate
how
healthy
diet
can
unhealthy
high-fat
reveal
link
between
microglia/diet
disease
outcomes
diet-derived
nanoparticles.
Cell Communication and Signaling,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: April 23, 2022
Abstract
Background
Microglia-mediated
neuroinflammatory
response
following
traumatic
brain
injury
(TBI)
is
considered
as
a
vital
secondary
factor,
which
drives
trauma-induced
neurodegeneration
and
lack
of
efficient
treatment.
ACT001,
sesquiterpene
lactone
derivative,
reportedly
involved
in
alleviation
inflammatory
response.
However,
little
known
regarding
its
function
regulating
innate
immune
central
nervous
system
(CNS)
after
TBI.
This
study
aimed
to
investigate
the
role
underlying
mechanism
ACT001
Methods
Controlled
cortical
impact
(CCI)
models
were
used
establish
model
Cresyl
violet
staining,
evans
blue
extravasation,
neurobehavioral
assessments,
immunofluorescence
transmission
electron
microscopy
evaluate
therapeutic
effects
vivo.
Microglial
depletion
was
induced
by
administering
mice
with
colony
stimulating
factor
1
receptor
(CSF1R)
inhibitor,
PLX5622.
Cell-cell
interaction
established
co-culture
simulate
TBI
conditions
vitro.
Cytotoxic
effect
on
cell
viability
assessed
counting
kit-8
activation
microglia
cells
Lipopolysaccharides
(LPS).
Pro-inflammatory
cytokines
expression
determined
Real-time
PCR
nitric
oxide
production.
Apoptotic
detected
TUNEL
flow
cytometry
assays.
Tube
formation
performed
cellular
angiogenic
ability.
ELISA
western
blot
experiments
determine
proteins
expression.
Pull-down
assay
analyze
that
bound
ACT001.
Results
relieved
extent
blood-brain
barrier
integrity
damage
alleviated
motor
deficits
via
reducing
cells.
Delayed
PLX5622
hindered
Furthermore,
LPS-induced
mouse
rat
primary
Besides,
effective
suppressing
pro-inflammatory
production
BV2
cells,
resulting
reduction
neuronal
apoptosis
HT22
improvement
tube
bEnd.3
Mechanism
functioned
related
AKT/NFκB/NLRP3
pathway.
restrained
NFκB
nuclear
translocation
through
inhibiting
AKT
phosphorylation,
decrease
NLRP3
inflammasome
activation,
finally
down-regulated
microglial
Conclusions
Our
indicated
played
critical
microglia-mediated
might
be
novel
potential
chemotherapeutic
drug
for
Frontiers in Neurology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 7, 2023
Microglia
are
the
principal
resident
immune
cells
in
central
nervous
system
(CNS)
and
play
important
roles
development
of
CNS
disorders.
In
recent
years,
there
have
been
significant
developments
our
understanding
microglia,
we
now
greater
insight
into
temporal
spatial
patterns
microglia
activation
a
variety
disorders,
as
well
interactions
between
neurons.
A
signaling
pathways
implicated.
However,
to
date,
all
published
clinical
trials
failed
demonstrate
efficacy
over
placebo.
This
review
summarizes
results
studies
attempts
provide
mechanistic
view
activation,
inflammation,
tissue
repair,